Written and maintained by CASRAI Editorial Board
Last updated
SignNow (owned by airSlate) is one of the most-searched-for e-signature tools among research administrators, and for good reason: it undercuts DocuSign and Adobe Sign on price while still covering the workflow features a grants office, IRB coordinator, or clinical research team actually needs — templates, role-based signing order, and an API for tying signatures into a CRM or intake form. This review looks at where it earns that reputation, where it falls short, and — honestly — when a research office is better served by a different kind of tool entirely.
Tip: try code CASRAI at checkout for 15% off, if the offer is currently active for this program — codes vary by vendor and aren’t guaranteed.
What SignNow actually does well
SignNow’s core pitch is a full e-signature workflow, not just a “click to sign” widget. On its own product pages, SignNow describes the ability to “sign documents online, generate agreements, negotiate contracts, and accept payments with legally-binding eSignatures,” with signatures created by typing, drawing, or uploading an image (verified 2026-08-26). For a research office that’s cycling the same handful of document types — consent forms, budget justifications, IRB amendment cover sheets, subrecipient agreements — that maturity shows up in three places:
- Signing workflow depth. Multi-party routing with a defined signing order, in-person signing, and conditional fields are all native, not bolted on.
- Compliance posture. SignNow states it maintains “HIPAA and CFR Part 11 Compliant” capabilities, alongside SOC 2 Type II, GDPR, and PCI DSS claims (verified 2026-08-26) — see the HIPAA FAQ below for the important caveat on which plan tier that actually applies to.
- Ecosystem reach. Native integrations with Salesforce, Google Workspace, NetSuite, and Microsoft products mean a research office already living in one of those systems doesn’t have to bolt signing on as a separate silo.
If your office already has a settled opinion that DocuSign is the “safe” institutional default, see CASRAI’s SignNow vs DocuSign comparison for the head-to-head on BAA tier placement, envelope allowances, and cost at scale — this review instead treats SignNow on its own terms.
Templates and reusable workflows
Templates are where SignNow’s maturity is most visible day to day. The product supports unlimited templates on paid tiers, with customizable fillable fields and the ability to organize documents into groups that route automatically to recipients in a defined, role-based order (verified against SignNow’s own product pages, 2026-08-26). For a research administration office, that means:
- A standard consent form template that routes to the PI, then the participant, then a witness, without anyone manually re-adding recipients each time.
- A subaward or MOU template with the same fillable-field layout across every subrecipient, cutting the manual re-formatting that otherwise creeps in when templates live as static Word documents.
- Grouped document sets — for example, a full IRB continuing-review packet — that move through sign-off as one unit rather than as separate one-off sends.
This is a genuine strength, and it’s the single feature area where SignNow’s product is noticeably more built-out than a bundled e-signature feature living inside a general-purpose PDF editor.
SignNow API and integrations
Beyond the point-and-click app, SignNow offers what its own site calls a “powerful API” intended to “deliver a seamless eSignature experience from any website, CRM, or custom app” (verified 2026-08-26). In practice this is used by research offices to embed signing directly into an internal intake portal — a participant fills out a REDCap-style form and the consent document is generated and routed for signature without a human manually uploading it into a separate signing tool. Native, pre-built integrations (Salesforce, Google Workspace, NetSuite, Gmail, Microsoft) cover the common case without needing custom API work at all.
This API and integration depth is a real differentiator versus a signing feature that lives only as a menu item inside a document editor — it’s built for developers to extend, not just for an end user to click through.
Pricing tiers explained
A pricing note up front: SignNow’s own pricing page redirects to a commerce checkout application that doesn’t return readable pricing content to an automated fetch, so the figures below are third-party-reported, not pulled directly off SignNow’s live pricing page as of this writing (checked 2026-08-26). Treat them as indicative and confirm current numbers directly with SignNow before budgeting.
- Business — reported around $8/user/month on annual billing.
- Business Premium — reported around $15/user/month on annual billing.
- Enterprise — reported around $30/user/month on annual billing.
All three standard tiers are reported to meter 100 signature invites per user per year, with overage pricing that scales by tier (roughly $0.96 / $1.80 / $3.60 per extra invite, third-party-reported). That per-user-per-year invite model is worth flagging explicitly: it’s the same structure DocuSign uses, and it systematically misprices an office whose volume is driven by a funding cycle or an enrollment wave rather than steady headcount — a small IRB office running one seasonal consent-form push can blow through its invite allotment on a handful of accounts while a large, steady-state office never comes close. HIPAA coverage with a signed BAA is reported to sit only on SignNow’s quote-only Site License plan, not on the standard published tiers — confirm this directly with a SignNow sales contact before assuming a mid-tier plan clears your institution’s compliance bar.
Who should consider a PDF-editor bundle instead
Here’s the honest tradeoff this review exists to make explicit: if signing depth — routing logic, template sophistication, API extensibility — is what your office actually needs, SignNow’s dedicated signing workflow and integrations are more mature than what you’ll get from a signing feature bundled inside a general PDF editor. Don’t switch away from that maturity to chase a bundle discount.
But signing is rarely the only thing a research office does to a PDF. Consent forms get redacted before they’re shared outside the study team. Budget justifications get merged, split, and re-annotated across a dozen revision cycles. IRB submission packets get assembled from a stack of separate PDFs into one clean document. If your office’s actual daily friction is less “we need better signing workflows” and more “we’re constantly opening a separate tool to redact, edit, merge, or annotate PDFs before or after they get signed,” that’s a genuinely different problem, and it’s worth looking at Foxit eSign specifically because it isn’t sold as a standalone signing tool — it’s an e-signature feature bundled inside Foxit’s PDF editor, alongside redaction, markup, and document assembly. That bundling is the honest differentiator: you’re not getting a deeper signing tool than SignNow, you’re getting a decent signing tool plus a full PDF editor in one subscription instead of two.
A useful way to decide: if you’d describe your office’s problem as “we need a better way to route documents for signature,” stay with SignNow (or read the SignNow vs DocuSign and HIPAA-compliant e-signature comparisons for the dedicated-tool shortlist). If you’d describe it as “we keep needing to redact, edit, or reassemble the PDF itself, and signing is just one step in that,” a PDF-editor-plus-eSign bundle like Foxit is worth a serious look, and CASRAI’s Foxit PDF Editor review covers the redaction and markup side in more depth than fits here.
FAQ: Is SignNow good for HIPAA-covered research?
SignNow states it offers HIPAA and 21 CFR Part 11 compliance capabilities on its platform generally, but third-party pricing reporting indicates that a signed Business Associate Agreement (BAA) — the actual legal instrument that makes a vendor HIPAA-usable for covered data, not just “HIPAA-capable” in marketing language — is available only on SignNow’s quote-only Site License plan, not the standard published Business, Business Premium, or Enterprise tiers. If your research office handles PHI (consent forms tied to identifiable health data, clinical trial documentation, etc.), don’t assume a mid-tier plan clears your compliance bar on marketing language alone — get the BAA commitment in writing from SignNow sales before signing a contract.
FAQ: Does SignNow have a mobile app?
Yes. SignNow offers dedicated iOS and Android apps that let users sign documents electronically without needing an internet connection at the moment of signing — useful for field-based consent collection (a home-visit study, an outreach clinic) where connectivity can’t be assumed. This is a genuine, verifiable feature (confirmed against SignNow’s own site, 2026-08-26), not a “works fine in a mobile browser” stand-in.
The bottom line
SignNow is a legitimately strong, well-priced dedicated e-signature tool, and for an office whose real bottleneck is signing workflow — templates, routing, API-driven automation — it’s a reasonable default that beats DocuSign on price without giving up much workflow depth. That dedicated-tool maturity is real, and CASRAI recommends SignNow (or a comparable dedicated signing product) whenever signing depth is genuinely the priority. Where it’s worth pausing is if your office’s actual pain point sits one step earlier or later in the document’s life — the redacting, editing, and assembling that happens around the signature, not the signature itself. In that specific case, a bundled option like Foxit eSign is worth evaluating, not because it out-signs SignNow, but because it doesn’t ask you to pay for two subscriptions to solve one document workflow.
